Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments

Gliomas are one of the most lethal types of cancers accounting for ∼80% of all central nervous system (CNS) primary malignancies. Among gliomas, glioblastomas (GBM) are the most aggressive, characterized by a median patient survival of fewer than 15  months. Recent molecular characterization studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Alghamri, Mahmoud S., McClellan, Brandon L., Hartlage, Carson S., Haase, Santiago, Faisal, Syed Mohd, Thalla, Rohit, Dabaja, Ali, Banerjee, Kaushik, Carney, Stephen V., Mujeeb, Anzar A., Olin, Michael R., Moon, James J., Schwendeman, Anna, Lowenstein, Pedro R., Castro, Maria G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167057/
https://www.ncbi.nlm.nih.gov/pubmed/34084145
http://dx.doi.org/10.3389/fphar.2021.680021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167057/
https://www.ncbi.nlm.nih.gov/pubmed/34084145
http://dx.doi.org/10.3389/fphar.2021.680021

Ejemplares similares